InspireMD (NSPR) Net Income towards Common Stockholders (2010 - 2025)

InspireMD's Net Income towards Common Stockholders history runs 16 years deep, the most recent figure standing at -$75.7 million for Q4 2025.

• In Q4 2025, Net Income towards Common Stockholders fell 30.89% year-over-year to -$75.7 million; the TTM figure through Dec 2025 stood at -$113.2 million (down 38.14% YoY), while the FY2025 annual figure was -$49.9 million, down 97.7% from the prior year.
• Net Income towards Common Stockholders for Q4 2025 stood at -$75.7 million, down from -$13.1 million in the prior quarter.
• The five-year high for Net Income towards Common Stockholders was -$3.2 million in Q1 2021, with the low at -$75.7 million in Q4 2025.
• The 5-year median for Net Income towards Common Stockholders is -$5.5 million (2023), against an average of -$13.0 million.
• The sharpest annual moves came in 2021 and 2023: Net Income towards Common Stockholders jumped 89.57% in 2021, then sank 251.69% in 2023.
• InspireMD's Net Income towards Common Stockholders stood at -$4.1 million in 2021, then declined by 18.88% to -$4.8 million in 2022, then tumbled by 251.69% to -$16.9 million in 2023, then plunged by 241.17% to -$57.8 million in 2024, then sank by 30.89% to -$75.7 million in 2025.
• Business Quant data shows NSPR's Net Income towards Common Stockholders at -$75.7 million in Q4 2025, -$13.1 million in Q3 2025, and -$13.0 million in Q2 2025.